|
FANCB expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 9.79629999999787E-05 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.438000E-04 |
| Normal-vs-Stage2 |
2.13940000000079E-05 |
| Normal-vs-Stage3 |
2.154700E-04 |
| Normal-vs-Stage4 |
2.07339999999112E-05 |
| Stage1-vs-Stage2 |
8.419800E-02 |
| Stage1-vs-Stage3 |
6.892200E-01 |
| Stage1-vs-Stage4 |
7.865800E-02 |
| Stage2-vs-Stage3 |
2.382600E-01 |
| Stage2-vs-Stage4 |
9.988800E-01 |
| Stage3-vs-Stage4 |
2.318000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.959420E-04 |
| Normal-vs-AfricanAmerican |
7.786400E-04 |
| Normal-vs-Asian |
3.980200E-04 |
| Caucasian-vs-AfricanAmerican |
6.255400E-01 |
| Caucasian-vs-Asian |
8.531400E-01 |
| AfricanAmerican-vs-Asian |
7.398800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.76329999999459E-05 |
| Normal-vs-Female |
1.446450E-04 |
| Male-vs-Female |
3.578400E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.199200E-04 |
| Normal-vs-Age(41-60Yrs) |
3.74180000000113E-05 |
| Normal-vs-Age(61-80Yrs) |
1.629980E-04 |
| Normal-vs-Age(81-100Yrs) |
7.197700E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.099600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.830600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.811000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.268400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.667800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.992200E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.640600E-01 |
| Classical-VS-Follicular |
2.442200E-02 |
| Classical-VS-Other |
3.022400E-01 |
| Classical-VS-Normal |
4.584600E-04 |
| Tall-VS-Follicular |
2.416200E-01 |
| Tall-VS-Other |
4.087000E-01 |
| Tall-VS-Normal |
3.683900E-03 |
| Follicular-VS-Other |
8.113600E-01 |
| Follicular-VS-Normal |
2.35269999999677E-05 |
| Other-VS-Normal |
4.780900E-03 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.10939999999838E-05 |
| Normal-vs-N1 |
4.47660000000294E-05 |
| N0-vs-N1 |
6.777800E-01 |
|
|
